Nilesh Sureshchandra Chordiya

Nilesh Sureshchandra Chordiya

Active Director Additional Director DIN 07884802
DIN 07884802 First appointment Feb 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Feb 2019
Shareholding value •••• Premium profile

About Nilesh Sureshchandra Chordiya

Data last updated:

Nilesh Sureshchandra Chordiya is an Additional Director at Cytocure Medicare Private Limited (since 2022), Director at Spj Onco Care Private Limited (since 2021) and Designated Partner at Specialty Surgical Oncology Llp (since 2021), and holds 1 more current directorship. The companies operate in Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹64.83 Cr; the largest is Cytocure Medicare Private Limited at ₹55.94 Cr (FY 2025). Earlier, Nilesh Sureshchandra Chordiya was a Director at Clinitial Medicaid Private Limited (from 2019).

DIN 07884802
Primary Designation Additional Director
Industry Healthcare
First Appointment 14 Feb 2019
Oldest Company Age 7 yrs
Largest company Cytocure Medicare Private Limited · ₹55.94 Cr (FY 2025)
Combined revenue ₹64.83 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cytocure Medicare Private Limited U85300MH2019PTC319108
Additional Director17 Nov 20222019₹55.94 Cr (FY 2025)Active
Spj Onco Care Private Limited U74999MH2018PTC317531
Director01 Mar 20212018₹8.88 Cr (FY 2025)Active
Designated Partner17 Aug 20212021₹89,520 (FY 2023)Active
Designated Partner09 Aug 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Clinitial Medicaid Private Limited U85300MH2019PTC321270
Director14 Feb 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Spj Onco Care Private Limited
Clinitial Medicaid Private Limited
Cytocure Medicare Private Limited
Specialty Surgical Oncology Llp
Premium access

Shareholding and investment profile for Nilesh Sureshchandra Chordiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilesh Sureshchandra Chordiya

Nilesh Sureshchandra Chordiya currently holds 4 directorships: Cytocure Medicare Private Limited (Additional Director, since 17 Nov 2022, revenue ₹55.94 Cr (FY 2025)); Spj Onco Care Private Limited (Director, since 01 Mar 2021, revenue ₹8.88 Cr (FY 2025)); Specialty Surgical Oncology Llp (Designated Partner, since 17 Aug 2021, revenue ₹89,520 (FY 2023)); Pred Healthcare Solutions Llp (Designated Partner, since 09 Aug 2021).

Nilesh Sureshchandra Chordiya was first appointed on 14 Feb 2019 as Director at Clinitial Medicaid Private Limited. The most recent appointment on record is 17 Nov 2022 at Cytocure Medicare Private Limited.

The 3 current companies of Nilesh Sureshchandra Chordiya that report revenue have a combined latest revenue of ₹64.83 Cr: Cytocure Medicare Private Limited ₹55.94 Cr (FY 2025); Spj Onco Care Private Limited ₹8.88 Cr (FY 2025); Specialty Surgical Oncology Llp ₹89,520 (FY 2023).

Nilesh Sureshchandra Chordiya held 1 earlier board appointment: Clinitial Medicaid Private Limited (Director, from 14 Feb 2019).

The current boards of Nilesh Sureshchandra Chordiya's companies include Jageshwar Prasad Pandey (Cytocure Medicare Private Limited), Sanket Sharad Mehta (Cytocure Medicare Private Limited), Amit Balai Chakraborty (Spj Onco Care Private Limited), Chetan Anchan (Spj Onco Care Private Limited), Jay Rashmi Anam (Spj Onco Care Private Limited), Praveen Shrinivas Kammar (Spj Onco Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available